Small

Zacks Small Cap Research – RVPH: Preliminary OLE Readout – Go Health Pro

by
Zacks Small Cap Research – RVPH: Preliminary OLE Readout – Go Health Pro

By John Vandermosten, CFA NASDAQ:RVPH READ THE FULL RVPH RESEARCH REPORT Open Label Extension Initial Readout Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported preliminary results from its open label extension (OLE) portion of the Phase III RECOVER trial. Brilaroxazine showed a favorable long-term safety profile and improving efficacy over the one-year observation period. The schizophrenia candidate … Read more

Zacks Small Cap Research – MTVA: Compelling Data for DA-1241 in Phase 2a MASH Trial… – Go Health Pro

by
Zacks Small Cap Research – MTVA: Compelling Data for DA-1241 in Phase 2a MASH Trial… – Go Health Pro

By David Bautz, PhD NASDAQ:MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Compelling Results for DA-1241 in Phase 2a MASH Trial On December 18, 2024, MetaVia Inc. (NASDAQ:MTVA) announced positive topline results from the 16-week Phase 2a clinical trial of DA-1241 in patients with presumed metabolic dysfunction-associated steatohepatitis (MASH). The trial had two parts: … Read more

7 Best Payroll Services For Small Business Of 2024 – Forbes Advisor – Go Health Pro

by
7 Best Payroll Services For Small Business Of 2024 – Forbes Advisor – Go Health Pro

Toronto-based Wave is a relatively new player in small business financial services, and it’s making its name by building a user-friendly and affordable platform that addresses the unique needs of freelancers, contractors and small business owners. Payroll is Wave’s latest feature. It comes to the platform along with accounting, invoicing and payment processing for small … Read more

Sweat the small stuff: Data protection in the age of AI – Go Health Pro

by
Sweat the small stuff: Data protection in the age of AI – Go Health Pro

As concerns about AI security, risk, and compliance continue to escalate, practical solutions remain elusive. While NIST released NIST-AI-600-1, Artificial Intelligence Risk Management Framework: Generative Artificial Intelligence Profile on July 26, 2024, most organizations are just beginning to digest and implement its guidance, with the formation of internal AI Councils as a first step in … Read more

Zacks Small Cap Research – MIRA Makes Major Strides – Go Health Pro

by

By Brad Sorensen, CFA NASDAQ:MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company that is about to be a clinical-stage company focused on the development and commercialization of a new molecular synthetic cannabinoid analog for the treatment of adult patients with neuropathic pain as well as anxiety and cognitive … Read more

x